Vanguard Group Inc Pulse Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,146,339 shares of PLSE stock, worth $24.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,146,339
Previous 995,833
15.11%
Holding current value
$24.3 Million
Previous $17.5 Million
21.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PLSE
# of Institutions
78Shares Held
5.75MCall Options Held
94.9KPut Options Held
52K-
Black Rock Inc. New York, NY1.15MShares$24.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC788KShares$16.7 Million0.0% of portfolio
-
State Street Corp Boston, MA474KShares$10.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA461KShares$9.78 Million0.0% of portfolio
-
Griffin Asset Management, Inc.238KShares$5.04 Million0.53% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $788M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...